Seqens Seqens

X

Find the latest news about Teva Pharmaceutical Industries aggregated by PharmaCompass.com.

Client Virtual Booth
  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Teva Pharmaceutical Industries
Israel Flag
Country
Country
Israel
Address
Address
5 Basel St., Petach Tikva Israel, 49131
Telephone
Telephone
+972-3-9267267
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2024-82633.pdf

FDA
17 Apr 2024

https://www.fiercepharma.com/pharma/richard-francis-jumps-top-biopharma-pay-rankings-his-first-year-tevas-new-ceo

Fraiser Kansteiner FIERCE PHARMA
17 Apr 2024

https://www.pharmaceutical-technology.com/news/alvotech-teva-fda-selarsdi/

PHARMACEUTICAL TECHNOLOGY
17 Apr 2024

https://www.europeanpharmaceuticalreview.com/news/226663/teva-enters-into-oncology-biosimilar-licensing-agreement/

Catherine Eckford EUROPEAN PHARMACEUTICAL REVIEW
16 Apr 2024

https://www.reuters.com/legal/litigation/pfizers-wyeth-reaches-39-million-settlement-effexor-xr-antitrust-case-2024-04-10/

REUTERS
11 Apr 2024

https://www.businesswire.com/news/home/20240411323269/en

BUSINESSWIRE
11 Apr 2024

https://www.businesswire.com/news/home/20240406098130/en

BUSINESSWIRE
06 Apr 2024

https://www.businesswire.com/news/home/20240404077528/en

BUSINESSWIRE
04 Apr 2024

https://www.fiercepharma.com/pharma/teva-forging-ahead-pivot-growth-campaign-inks-biosimilar-licensing-deal-spains-mabxience

Fraiser Kansteiner FIERCE PHARMA
04 Apr 2024

https://www.businesswire.com/news/home/20240403581964/en

BUSINESSWIRE
03 Apr 2024
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY